SCHEMBL20469165

SCHEMBL20469165

N=C/C(=C\NC(F)F)c1ccc(C=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ PARP10 Q53GL7 1/20 0.36
▸ PARP3 Q9Y6F1 1/20 0.36
▸ ALDH5A1 P51649 1/20 0.34
▸ ABAT P80404 1/20 0.34
▸ DRD1 P21728 2/20 0.33
▸ TYR P14679 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ADRB2 P07550 1/20 0.31
▸ ADRB1 P08588 1/20 0.31
▸ ADRB3 P13945 1/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ KCNJ1 P48048 1/20 0.30
▸ EPHX2 P34913 1/20 0.30
▸ NR1H4 Q96RI1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24018468 0.80 HPGD (0.34) ALDH1A1
SCHEMBL22084639 0.74 ALDH1A1 (0.42) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL21012719 0.73 ALDH1A1 (0.38) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL23912321 0.73 ALDH1A1 (0.41) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL23511032 0.72 ALDH1A1 (0.40) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL22084095 0.72 ALDH1A1 (0.47) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL20469160 0.71 ALDH1A1 (0.39) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL23912318 0.68 ALDH1A1 (0.43) ALDH1A1PARP10PARP3KDM4EADRB2
SCHEMBL22926330 0.68 ALDH1A1 (0.42) ALDH1A1PARP10PARP3ALDH5A1ABAT
SCHEMBL20469211 0.64 ALDH1A1 (0.50) ALDH1A1PARP10PARP3ALDH5A1ABAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909949-A1 ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS Gilead Sciences, Inc. (US) 2021-11-17 — — EP disclosed
EP-3577110-B1 8-OXETAN-3-YL-3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL SUBSTITUTED COMPOUNDS AS HIV INHIBITORS GILEAD SCIENCES INC (US) 2021-04-21 — — EP disclosed
WO-2018145021-A1 ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS GILEAD SCIENCES, INC. (US) 2018-08-09 — — WO disclosed
Send feedback